ESAB reported Q4 2025 sales of USD 721 million (+7%), with net income from continuing operations attributable to shareholders of USD 50 million (USD 0.82 per diluted share) and core adjusted net income of USD 83 million (USD 1.35 per diluted share). Q4 core adjusted EBITDA was USD 140 million (+9%), with a core adjusted EBITDA margin of 20.4% (up 10 basis points), while core organic sales declined 2%. For FY 2025, ESAB reported sales of USD 2.84 billion (+4%), net income from continuing operations attributable to shareholders of USD 259 million (USD 4.10 per diluted share), and core adjusted net income of USD 324 million (USD 5.27 per diluted share). FY core adjusted EBITDA was USD 540 million (+6%), with a core adjusted EBITDA margin of 20.0% (up 30 basis points), and core organic sales were flat. ESAB reiterated its FY 2026 outlook, expecting core organic growth of 2.0% to 4.0% and total core sales growth of 6.0% to 9.0%, including a 0.0% to 1.0% currency tailwind and approximately 4% M&A growth, along with core adjusted EBITDA of USD 575 million to USD 595 million and core adjusted EPS of USD 5.70 to USD 5.90.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ESAB Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001877322-26-000008), on February 20, 2026, and is solely responsible for the information contained therein.
Comments